Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for prevention of type 2 diabetes after gestational diabetes
2018-002425-34Phase 2Completed
- Sponsor
- Turku University Hospital
- Start
- Jul 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in type 2 diabetes mellitus (T2DM), dysglycemia, sponsored by Turku University Hospital. Started Jul 2019; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)dysglycemia
Beyond the preview
Go deeper on 2018-002425-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002425-34.